These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 22079317)

  • 1. Genistein inhibits aggregation of exogenous amyloid-beta₁₋₄₀ and alleviates astrogliosis in the hippocampus of rats.
    Bagheri M; Roghani M; Joghataei MT; Mohseni S
    Brain Res; 2012 Jan; 1429():145-54. PubMed ID: 22079317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genistein ameliorates learning and memory deficits in amyloid β(1-40) rat model of Alzheimer's disease.
    Bagheri M; Joghataei MT; Mohseni S; Roghani M
    Neurobiol Learn Mem; 2011 Mar; 95(3):270-6. PubMed ID: 21144907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of tumor necrosis factor-alpha central administration on hippocampal damage in rat induced by amyloid beta-peptide (25-35).
    Stepanichev MY; Zdobnova IM; Yakovlev AA; Onufriev MV; Lazareva NA; Zarubenko II; Gulyaeva NV
    J Neurosci Res; 2003 Jan; 71(1):110-20. PubMed ID: 12478619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective effect of the aminoestrogen prolame against impairment of learning and memory skills in rats injected with amyloid-β-25-35 into the hippocampus.
    Limón D; Díaz A; Hernandez M; Fernandez-G JM; Torres-Martínez AC; Pérez-Severiano F; Rendón-Huerta EP; Montaño LF; Guevara J
    Eur J Pharmacol; 2012 Jun; 685(1-3):74-80. PubMed ID: 22542664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Puerarin attenuates amyloid-beta-induced cognitive impairment through suppression of apoptosis in rat hippocampus in vivo.
    Li J; Wang G; Liu J; Zhou L; Dong M; Wang R; Li X; Li X; Lin C; Niu Y
    Eur J Pharmacol; 2010 Dec; 649(1-3):195-201. PubMed ID: 20868658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of the sialylation pattern and memory deficits by injection of Aβ(25-35) into the hippocampus of rats.
    Limón ID; Ramírez E; Díaz A; Mendieta L; Mayoral MÁ; Espinosa B; Guevara J; Zenteno E
    Neurosci Lett; 2011 May; 495(1):11-6. PubMed ID: 21419829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of genistein on the content and activity of α- and β-secretase and protein kinase C in Aβ-injured hippocampal neurons.
    Liao W; Jin G; Zhao M; Yang H
    Basic Clin Pharmacol Toxicol; 2013 Mar; 112(3):182-5. PubMed ID: 22994425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-amyloid pathology in the entorhinal cortex of rats induces memory deficits: implications for Alzheimer's disease.
    Sipos E; Kurunczi A; Kasza A; Horváth J; Felszeghy K; Laroche S; Toldi J; Párducz A; Penke B; Penke Z
    Neuroscience; 2007 Jun; 147(1):28-36. PubMed ID: 17499931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid-beta(25-35)-induced memory impairments correlate with cell loss in rat hippocampus.
    Stepanichev MY; Zdobnova IM; Zarubenko II; Moiseeva YV; Lazareva NA; Onufriev MV; Gulyaeva NV
    Physiol Behav; 2004 Feb; 80(5):647-55. PubMed ID: 14984798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyloid beta(1-40)-induced astrogliosis and the effect of genistein treatment in rat: a three-dimensional confocal morphometric and proteomic study.
    Bagheri M; Rezakhani A; Nyström S; Turkina MV; Roghani M; Hammarström P; Mohseni S
    PLoS One; 2013; 8(10):e76526. PubMed ID: 24130779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-aggregated Aβ(25-35) alters arginine metabolism in the rat hippocampus and prefrontal cortex.
    Liu P; Jing Y; Collie ND; Campbell SA; Zhang H
    Neuroscience; 2011 Oct; 193():269-82. PubMed ID: 21807072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic efficacy of stemazole in a beta-amyloid injection rat model of Alzheimer's disease.
    Han M; Liu Y; Tan Q; Zhang B; Wang W; Liu J; Zhang XJ; Wang YY; Zhang JM
    Eur J Pharmacol; 2011 Apr; 657(1-3):104-10. PubMed ID: 21316359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of insulin on the cognizing function and expression of hippocampal Abeta1-40 of rat with Alzheimer disease.
    Jiang LH; Zhang YN; Wu XW; Song FF; Guo DY
    Chin Med J (Engl); 2008 May; 121(9):827-31. PubMed ID: 18701049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective role of melatonin in domoic acid-induced neuronal damage in the hippocampus of adult rats.
    Ananth C; Gopalakrishnakone P; Kaur C
    Hippocampus; 2003; 13(3):375-87. PubMed ID: 12722978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of bFGF on neuronal damage induced by sequential treatment of amyloid β and excitatory amino acid in vitro and in vivo.
    Noshita T; Murayama N; Oka T; Ogino R; Nakamura S; Inoue T
    Eur J Pharmacol; 2012 Nov; 695(1-3):76-82. PubMed ID: 23026373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble oligomeric forms of beta-amyloid (Abeta) peptide stimulate Abeta production via astrogliosis in the rat brain.
    Perez JL; Carrero I; Gonzalo P; Arevalo-Serrano J; Sanz-Anquela JM; Ortega J; Rodriguez M; Gonzalo-Ruiz A
    Exp Neurol; 2010 Jun; 223(2):410-21. PubMed ID: 19879263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ß-amyloid-related peptides potentiate K+-evoked glutamate release from adult rat hippocampal slices.
    Kabogo D; Rauw G; Amritraj A; Baker G; Kar S
    Neurobiol Aging; 2010 Jul; 31(7):1164-72. PubMed ID: 18819729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of tanshinone on neuropathological changes induced by amyloid beta-peptide(1-40) injection in rat hippocampus.
    Li LX; Dai JP; Ru LQ; Yin GF; Zhao B
    Acta Pharmacol Sin; 2004 Jul; 25(7):861-8. PubMed ID: 15210058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Tong Luo Jiu Nao on Aβ-degrading enzymes in AD rat brains.
    Liu Y; Hua Q; Lei H; Li P
    J Ethnopharmacol; 2011 Sep; 137(2):1035-46. PubMed ID: 21798326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel anti-inflammatory compound SEN1176 alleviates behavioral deficits induced following bilateral intrahippocampal injection of aggregated amyloid-β₁₋₄₂.
    O'Hare E; Scopes DI; Treherne JM; Monaghan J; Palmer PM; Amijee H; Kim EM
    J Alzheimers Dis; 2011; 25(2):219-29. PubMed ID: 21654060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.